Creative Planning - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 90 filers reported holding GW PHARMACEUTICALS PLC in Q2 2014. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.

Quarter-by-quarter ownership
Creative Planning ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$875,000
+76.4%
4,034
-6.2%
0.00%
+100.0%
Q4 2020$496,000
+20.7%
4,302
+1.8%
0.00%0.0%
Q3 2020$411,000
-33.2%
4,225
-15.7%
0.00%
-50.0%
Q2 2020$615,000
+24.0%
5,014
-11.4%
0.00%0.0%
Q1 2020$496,000
-7.5%
5,661
-10.4%
0.00%0.0%
Q4 2019$536,000
-16.4%
6,316
+9.4%
0.00%0.0%
Q3 2019$641,000
-41.7%
5,774
-10.6%
0.00%
-50.0%
Q2 2019$1,099,000
-13.0%
6,462
-17.0%
0.00%
-20.0%
Q1 2019$1,263,000
+98.0%
7,783
+3.0%
0.01%
+66.7%
Q4 2018$638,000
-39.7%
7,553
+9.1%
0.00%
-25.0%
Q3 2018$1,058,000
+28.6%
6,921
+7.8%
0.00%
+33.3%
Q2 2018$823,000
+72.2%
6,418
+42.1%
0.00%
+50.0%
Q1 2018$478,000
-25.0%
4,515
-6.4%
0.00%
-33.3%
Q4 2017$637,000
+95.4%
4,822
+50.3%
0.00%
+50.0%
Q3 2017$326,000
+28.3%
3,208
+26.7%
0.00%
+100.0%
Q2 2017$254,000
-15.9%
2,532
+1.4%
0.00%
-50.0%
Q1 2017$302,000
+202.0%
2,497
+179.3%
0.00%
+100.0%
Q4 2016$100,000
-40.1%
894
-28.8%
0.00%0.0%
Q3 2016$167,000
+34.7%
1,256
-18.0%
0.00%0.0%
Q2 2016$124,000
+143.1%
1,532
+117.6%
0.00%
Q1 2016$51,000
-63.3%
704
-64.9%
0.00%
-100.0%
Q4 2015$139,000
-21.0%
2,004
+4.2%
0.00%
-50.0%
Q3 2015$176,000
+44.3%
1,924
+43.4%
0.00%
+100.0%
Q1 2015$122,000
-0.8%
1,342
-26.4%
0.00%0.0%
Q4 2014$123,000
-23.6%
1,824
-8.3%
0.00%
-50.0%
Q3 2014$161,000
-30.9%
1,989
-33.2%
0.00%
-33.3%
Q2 2014$233,000
+454.8%
2,979
+148.2%
0.00%
+200.0%
Q1 2014$42,0001,2000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2014
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 450,000$55,224,0004.41%
Parkman Healthcare Partners LLC 119,778$14,699,0004.14%
Sio Capital Management, LLC 94,984$11,656,0003.40%
Tamarack Advisers, LP 90,000$11,045,0003.08%
Copernicus Capital Management, LLC 22,000$2,700,0002.96%
Integral Health Asset Management, LLC 75,000$9,204,0002.76%
ETF MANAGERS GROUP, LLC 480,145$58,923,0002.09%
AdvisorShares Investments LLC 29,758$3,652,0001.55%
Redwood Investments, LLC 130,444$16,008,0001.42%
CLOUGH CAPITAL PARTNERS L P 100,746$12,364,0001.21%
View complete list of GW PHARMACEUTICALS PLC shareholders